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2Arguably Big Biology: Sociology, Spatiality and the Knockout Mouse Project
Gail Davies
A critical challenge, following the completion of the Human Genome Project, has been
how to make biological sense of the sequence data amassed and translate this into clinical
applications. A range of large biological research projects, as well as more distributed
experimental collaborations, are seeking to realise this through translational research
initiatives and postgenomic approaches. Drawing on interviews with key participants, this
paper explores the biological assumptions, sociological challenges and spatial imaginaries
at play in arguments around one of these developments, which is using genetically-altered
mice to understand gene function. The knockout mouse project (KOMP) is a large-scale
initiative in functional genomics, seeking to produce a ‘knockout mouse’ for each gene in
the mouse’s genome, which can then be used to answer questions about gene function in
mammals. KOMP is frequently framed as one successor to the Human Genome Project,
emblematic of the ambitions of internationally-coordination biological research. However,
the development of new technologies for generating and managing genetically-altered
mice, alongside the challenge of asking biologically meaningful questions of vast numbers
of animals, is creating new frictions in this extension and intensification of biological
research practices. This paper introduces two separate approaches to the future of
international research using mutant mice as stakeholders negotiate the biological,
sociological and spatial challenges of collaboration. The first centres on the directed
research practices and sociological assumptions of KOMP, as individual researchers are
reorganised around shared animals, databases and infrastructures. The second highlights an
alternative vision of the future of biomedical research, using distributed management to
enhance the sensitivities and efficiencies of existing experimental practices over space.
These exemplify two different tactics in the organisation of an ‘arguably’ big biology. They
also critically embody different sociological and spatial imaginaries for the collaborative
practices of international translational research.
Keywords: Big biology; functional genomics, Knockout Mouse Project (KOMP); mutant
mice; geographies of knowledge; spatiality.
3The Knockout Mouse Project
“The knockout [mouse] effort is arguably the largest international biological
research endeavor since the Human Genome Project” (Grimm, 2006: 1862)
This sentence is an intriguing invitation to consider the nature of big projects in the
contemporary biosciences. That international efforts to produce and characterize a
genetically-altered knockout mouse for every gene in the mouse genome is a large-scale
undertaking is perhaps self evident1. But what does the word ‘arguably’ signify in this
sentence? The alliterative juxtaposition of ‘arguably’, ‘international’ and ‘endeavour’ insert
this effort into debates about the changing scope and scale of big biological research (see
Davies, Leonelli and Frow, this volume). The adverb opens up questions about the way size
is achieved or claimed and the implications of framing internationally distributed research
as an identifiable project. It raises questions about the inheritance of the Human Genome
Project (HGP) as a model for big biology, and its influence on efforts by contemporary
biologists seeking to make biological sense of the genome sequences produced. The
hesitation in naming a successor to the Human Genome Project also raises questions about
the scientific status of large-scale biological infrastructures and the interrelations between
building access to biological resources and furthering experimental understandings. In this
paper, I argue these questions not only have implications for the way biology is being
organised, understood and practiced; they also indicate the co-existence of different ways
of thinking about the operation of scale and the organisation of space in collaborative
postgenomic research.
1 ‘Knockout mice’ are mice that have had their genome manipulated to eliminate a single gene. This
allows researcher to explore the effect this gene has on animal development and phenotype to help
decipher gene function. Knockout mice are only one of the many genetically-altered animals now
being produced. They differ from transgenic mice, which have had DNA from another species
introduced into their genome. Most knockout animals are produced through first generating targeted
knockout mutations in mouse embryonic stem cells. Embryos are extracted from mice 4 days after
fertilisation, and an inserted sequence of artificial DNA is used to switch off the specified gene. ES
cells are used because the gene will then be knocked out of all the adult tissues. The altered ES cells
are injected back into a mouse embryo, which is then implanted in an adult mouse uterus and
allowed to develop. The National Human Genome Research Institute has a fact sheer on Knockout
mice http://www.genome.gov/12514551 (last accessed 27.11.12)
4Policy accounts and scientific commentaries following the HGP have stressed two key
dynamics of contemporary large-scale biological research: scale and mobility. The first
refers to the scaling-up of DNA sequencing and the challenge of making sense of the huge
amounts of genome sequence data generated over the past 15 years. As the commentary by
The International Mouse Knockout Consortium (2007) explains ‘the great challenge facing
biologists today is to ascribe function to the thousands of genes discovered through these
efforts’ (2007: 9). The second dynamic is that of translational research, which gives
renewed attention to the mobility of knowledge and value across domains, notably in
developing new architectural and institutional forms which articulate the movement of
biological research from experimental to clinical settings (Franklin, 2006; Martin et al,
2008; Leonelli and Sunder Rajan, forthcoming). KOMP is an explicit attempt to address
both questions of scale and mobility in large-scale biological research: scaling-up
functional genomics by systematically manipulating the whole mouse genome to elucidate
gene function and translating research to help understand the contribution of mutant alleles
to inherited human diseases.
In this context, the word ‘arguably’ opens up consideration of whether the painstaking,
time-consuming and sometimes uncertain practices of generating, characterising, archiving
and distributing knockout mice actually coheres in a way that allows its identification as a
singular project of translational research. The organisation of KOMP is complex and
overlapping with other initiatives, involving researchers in many different institutions2. At
the highest level, KOMP is running alongside EUCOMM (the European Conditional
Mouse Mutagenesis project) and NorCOMM (the North American Conditional Mouse
Mutagenesis project) in international efforts to generate mouse gene knockouts. Within
KOMP there are a number of elements which articulate ‘to enhance the availability and
utility of mouse knockout strains’ (Collins et al, 2007: 9). Scientists developing the ES cell
precursors to new mouse model development are based in the University of California
Davis (UCD), Children's Hospital Oakland Research Institute and the Wellcome Trust
Sanger Centre in the UK, with additional support from the private pharmaceutical company
Regeneron. Distribution of these biological resources is facilitated by the KOMP
2 For further information see http://www.knockoutmouse.org/. Last accessed 16.03.2012.
5Repository at UCD, the European Mouse Mutant Cell Repository (EuMMCR) and the
European Mutant Mouse Archive (EMMA). There are some further 19 US health institutes
and other international centres helping understand the value of these mouse models for
human biology. Data coordination is centred on the Mouse Genome Informatics Database,
developed and curated by the Jackson Laboratories in Maine USA. Funding has been
provided by the US National Institutes of Health (NIH) for work in both the USA and
Europe, with additional resources from the European Union and The Wellcome Trust.
Together and separately, they are working to add biology back into genomics; breeding
mice from a known background strain with a known gene knocked-out, using these to
explore the links between gene and gene function, with the hope of developing new
understandings of mouse biology of value for human therapeutic applications. On the one
hand, this is large-scale functional genomics. On the other hand, it is a series of still-
emerging international and interdisciplinary initiatives, seeking economies of scale to
reduce the costs of animal model production and speed up the translation of genomic
research from basic biology to clinical application, but without a clear sense of the most
effective routes for achieving either reduction or translation.
There are thus further social scientific questions about how to understand the emergence
and coherence of these big biological projects, in ways which are attentive to their complex
dynamics and the disparate biological, social and other imaginaries which animate them. In
conversation with scientific researchers, some of whom are directly involved in KOMP and
some of whom are not,3 it is clear there is a critical third dimension to such large-scale
biology: that is the spatial imaginaries and logics shaping the ambitions and achievements
of large-scale biological research. These rarely feature in scientific commentaries, but are
3 This paper is based on research carried out for the ESRC fellowship ‘Biogeography and
Transgenic Life’. This traced the different ways mice are ‘on the move’ in contemporary
biomedical research: internationally, in the establishment of large-scale mutant mouse resource
centres; corporeally, in the development of further mouse models of human disease; and affectively,
in the changing ways these animals are figured in different scientific, regulatory and ethical
cultures. This paper is based on ethnographic research, literature review and in-depth interviews
with key scientists involved in and critiquing the development of KOMP, carried out in the UK,
USA and Singapore from 2008-2009. It is further informed by over 80 interviews with research
scientists, animal welfare scientists, regulators, patient groups and others involved in the changing
use of mouse models, as well as participation in research meetings and conferences. All research
participants were offered anonymity.
6increasingly the focus of social scientific research. Pioneering work by Parry (2004) on the
global trade in bio-information shows how the circulation and commodification of genetic
plant resources are layered onto spaces central to the earlier dynamics of plant collecting
(Parry 2004). Cooper has shown how the epistemologies of the life sciences are
increasingly being reshaped alongside the regulatory logics and economic spaces of
neoliberal economics (Cooper 2008). Further studies have explored the uneven geographies
at stake in the globalisation of biomedical experimental practices (Sunder Rajan 2006), as
well detailing the architectures which shape materiality and ethics within and between
specific laboratory and clinical spaces (Franklin 2006). In different ways these studies
demonstrate the complex intersections between the biological, sociological and spatial, at a
time when both postgenomics and the globalisation of science are opening up new
questions around the contextualisation of biological processes and the spatialisation of bio-
value.
Spatial questions have shaped my own ethnographic research on the changing production,
circulation and regulation of mice as model organisms in international biology (Davies
2011a, 2011b; 2012a; 2012b). In this paper, I explore how the spatial imaginaries
underpinning international research using mutant mice figure the sociological challenges of
collaboration and the emergence of biological insights in different ways. These are more
implicit than questions of scale or mobility, but they emerge when respondents reflect on
what a geographer might be doing researching a world of mice. This perhaps exploits the
ethnographic truism that respondents assume you are there for the same reasons they are,
but is intended as a generous engagement with spatial, social and biological assumptions
articulated as researchers reflect on the challenge of coordinating research practices across
infrastructures, disciplines and spaces. Here, I want to outline just two of these. The first
draws attention to the directed practices of KOMP and the emergence of sociological
challenges as researchers are rearticulated around uniform animals and shared databases.
The second highlights arguments for the more distributed management of biological
resources through questions about the efficiencies of monitoring practices and
understanding differences across space. These two modes of imagining and spatialising
research are not exclusive or exhaustive, but characterise a central tension between
7standardisation and heterogeneity, the articulation of community norms and the
management of biological excess, in the contexts of international translational research.
The Directed Practices of KOMP
The opportunities are huge. […] The challenges are getting the community to
buy into such an approach. It’s a little bit like the human genome project: it’s
expensive; it deflects resources into bigger centres. So, there’s all of those
negatives associated with it, and you have to convince people that the ultimate
value is going to be much greater if it happens (Scientist 1, UK 2008).
One of my interviews starts with the observation the only mouse this researcher works with
operates his computer. We probe the complexities of biological databases before talk turns
to the intersections of science, sociology and space. This researcher is integrating
information from the diversity of work done with mutant mice, through a database storing
gene expression data, for both wild-type mice and mutant mice. The gene expression
database is part of the larger mouse gene informatics system or MGI. This is a public
database aiming to assimilate information from ongoing mouse research and make it
available to the wider scientific community. This publicly accessible repository
incorporates data from existing scientific literature and other databases. It also helps the
extended parts of KOMP coordinate priorities across institutions. This is central to
KOMP’s aim of reducing the costs of using animals in research – costs to funders and to
the animals themselves – whilst speeding up research for those animals with most potential
as models for translational research. As he explains, ‘coordination means avoiding
redundancy of work and making informed decisions in terms of prioritisation’ (Scientist 2,
USA 2009). Reflecting on this, he suggests it makes a good case study for someone
interested in the geography, or international coordination, of science: ‘The KOMP data
coordination centre is a really nice example that works because there are a lot of things that
do not necessarily work as they are supposed to’ (Scientist 2, USA 2009). I prompt him to
develop this analysis for me. The resulting narrative takes the conversation back to the
founding of KOMP.
8The core aims of KOMP are detailed in an article collectively written for Nature Genetics
by the Comprehensive Knockout Mouse Project Consortium (2004)4. From the start, the
composite authorship makes clear a community is being forged alongside a biological
research project. The authors were involved in a series of meetings, commencing 2003 at
the Banbury Conference Centre at Cold Spring Harbor Laboratory in the USA, which
articulated an ambitious vision for the future of research using knockout mice. After
reviewing the patchy availability of fully characterised knockout mice in academic
literature, the paper lays out the objectives of KOMP as a coordinated initiative for the
generation of mouse ES cells and subsequent characterisation of mutant animals.
Centralisation is argued to produce benefits in terms of financial savings – the ‘economies
of scale in an organized and carefully planned project’ (The Comprehensive Knockout
Mouse Project Consortium, 2004: 921) – and in terms of biological standardisation – the
‘uniform use of knockout methods, allowing for more comparability’ (2004: 921). Yet
beyond these centralising practices, the overall aim of KOMP is outward looking and more
centrifugal – to ‘accelerate the translation of genome sequences into biological insights’
(2004: 921). It is also ultimately global in its language and aspirations. The paper
concludes: ‘this ambitious and historic initiative must be carried out as a collaborative
effort of the worldwide scientific community, so that all can contribute their skills, and all
can benefit’ (2004: 923).
There are thus two assumptions embedded in KOMP. The first is the epistemic and
ontological supposition that accelerating translational biomedical research is best achieved
through centralising biological resources. The second is the sociological presumption of a
worldwide scientific community, willing to share skills and benefits via a project led
largely by Euro-American scientists. Both are susceptible to a characteristically spatial
ambivalence, around what is gained from being gathered together and what is lost for those
places, people and practices finding themselves on the margins. There is also the complex,
but equally spatial, question about whether the most valuable insights for translational
4 There is an overlapping area of debate on establishing protocols for mouse sharing (Einhorn &
Heimes 2009). This is an important component to the realisation of KOMP, but full consideration of
changing property regimes for research animals exceeds the scope of this short paper.
9research, connecting laboratory research to clinics or communities, are going to emerge
from standing at the centre of things.
In seeking uniformity across knockout methods, a critical challenge for KOMP has been
agreeing the use of in-bred mouse strains and developing shared bio-ontologies for
describing genes and phenotypes. This standardisation is important for KOMP to contribute
experimental results, as well as research animals, to endeavours in functional genomics.
Tracing the effect of knockout genes on animal development requires a consistent and well-
characterised genetic background. Without, KOMP becomes a rather elaborate mechanism
for facilitating off-the-shelf access to a range of knockout mice; a potentially important
function, but arguably not science. Inbred mouse strains provide animals with known
genotype and phenotype, allowing researchers to identify experimental outcomes from
genetic alterations. But there are many different kinds of inbred mice. An initial decision
had to be made over which strain to use. The knockout mouse project is organised around
the mouse strain C57Black6. This was not an immediately obvious choice and it has some
consequences.
Proposed image here
The ES cell precursors used in KOMP were originally developed in the mouse strain 129
(Evans and Kaufman 1981). Yet its genetic background is complex and ‘messy’, the
animals have known neuro-anatomical abnormalities, and as adults they are slow to breed.
The C57Black6 had already become the favoured strain for researchers using transgenic,
rather than ES cell, techniques to genetically-alter mice. These animals are more resilient
breeders, and their widespread use means their phenotypes are better characterised5. At the
start of KOMP it was not known if it was possible to produce ES cell lines from the
C57Black6 mouse. The assumption was made that it was, but it was a risk. As one scientist
reflects: ‘sometimes we can get so full of ourselves, that we think we’re so good and
5 Much of this ubiquity comes from the simple fact they were the animal favoured by Elisabeth
Russell in the 1930s, who backcrossed many early genetic experiments onto this background strain
(Scientist 7, USA 2009). For further information on the history of making laboratory mice in the
USA see (Rader, 2004).
10
everything works so well on paper, that of course the biology will agree’ (Scientist 3, USA
2009). In the event, and in this case, the biology agreed. Markers of success are emerging in
papers suggesting ‘investigators are on the home stretch of the largest international
biological research initiative since the Human Genome Project’ (Dolgin 2011: 262).
Figures on the KOMP website6, show the expanding numbers of DNA vectors, ES lines
and mutant mice available from each centre. Yet, there are potential costs to this focus on a
single strain. Some of these derive from known issues with C57Black6 mice: they lose
hearing early; they may have behavioural issues; they also methylate DNA rapidly,
changing gene expression. There is also the risk of over-centralisation, such that research
on other strains is left undone and biological insights lost due to what one researcher called
these ‘Black6 blinkers’.
Further complexities emerge in standardising gene terminologies, bio-ontologies,
husbandry standards and phenotyping protocols used by different researchers. If
centralisation of data is the aim, then unambivalent knowledge of terms and practices is
required in advance. As my respondent suggests ‘we need to have a clear understanding of
what we actually mean before we do any coordination, otherwise it would create a huge
mess’ (Scientist 2, USA 2009). He explains how terminologies and practices change over
time and vary over space, with new generations of sequencing technologies and different
gene models in different databases. There is the challenge of standardising vocabularies to
codify phenotypes, such as three dimensional anatomical structures. There is also the
growing complexity of the animals themselves. KOMP is increasingly working with
conditional mutants, where genes can be switched on and off at different stages of
development, so vocabularies are required for a ‘genotype that is mosaic, and there is a
time-space aspect of the mutation’ (Scientist 2, USA 2009). These biological complexities
extend beyond the animal, as gene function is increasingly understood in relation to its
many environments, raising the tricky question of where to stop when key factors are still
unknown. He admits this is potentially irresolvable: ‘we were involved in a project where
we studied the impact of diet and drugs and environment. But where do you stop this
6 For updates see http://www.knockoutmouse.org/about/geneprogresssummary. Last accessed
16.3.12.
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collecting? Where do you? It could make a difference if there's one or two mice in the cage,
it might depend on the mood of the animal caretaker. I'm serious! You have to do
something that's reasonable, but it's always …’ (Scientist 2, USA 2009).
In addition to these biological complexities this is the growing realisation ‘the main
problems we have to deal with are sociological’ (Scientist 2, USA 2009). While trying to
resolve internal complications, they are also working to secure the external participation of
scientists. There are several issues here (see also Leonelli and Ankeny 2012). Some are the
immediate and well recognised ones to do with encouraging researchers to submit data
electronically. Scientists do not get credit for the electronic submission of data as they do
for publication, so incentives are low. The barriers can also seem high, as submission
requires initial investments in learning to format data for databases, something he suggests
researchers resent, even if they would spend significant periods learning new biological
techniques. Even when depositing data is a funding requirement, he suggests agencies are
hesitant to enforce data submission for fear of a backlash. Those building databases
recognise these sociological challenges and do their own market research: keeping weblogs
and posting surveys to ask how researchers are using their services and how they might be
improved.
There are further sociological challenges, which relate to securing scientists’ investment in
the more abstract scale and value of KOMP. Given the everyday costs of contributing to
centralised databases, scientists have to buy in to the vision that this is the best way to
progress research in functional genomics. The importance of ‘selling scale’ is emphasised
on both sides of Atlantic. As a UK scientist suggests, ‘the impediments are financial,
political, sociological to some degree. […] I think that probably the hardest one is to
convince the community that a big project of this scale is going to be hugely beneficial for
understanding what a genome is about’ (scientist 1, UK 2008). The extent to which
scientists value such big projects depends upon their research, their experiences and their
location. The importance of place emerges in comparison between the way European and
North American parts of KOMP are progressing: the difference between having central
funding or soft money available for data integration. In Europe, the emphasis has been on
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developing large-scale resources to integrate research from the outset, with the ultimate aim
of phenotyping the full-range of mutants; an inductive, open-ended empirical exploration
which seeks to encompass the whole mammalian genome7. In the US, the project had to fit
within the disease funding structures of the NIH, so phenotyping efforts were initially more
fragmented. With its focus on centrally funded research, and what one respondent identifies
as a commitment to furthering the ‘European project’ through science, integration between
databases has progressed more quickly in Europe. During my research there was a
suggestion the USA was playing catch up, albeit increasingly rapidly. However, these
international differences, and their divergent imaginaries of research community,
ownership and output, raise questions, for some, about the feasibility of full integration.
I think the whole model organism community and specifically the mouse
community in Europe, has over the past five years, really coalesced under these
European Union group projects. They’ve really focused on advancing the use of
mouse as a model system. So I think a lot of the data we’re getting from Europe
is because of that focus. There probably will be parallel types of resources
developed in Europe and elsewhere cooperatively, if not collaboratively. I mean
so maybe [X] will build something like the mouse phenome database but if he
does that, then the data that gets submitted to his database would also be shared
in a way that we could also access it and vice versa, even if we can’t get people
to all buy in. This is to me one of the stresses of globalisation. How many
databases do we need and who manages them? There’s always this thing about,
where is this resource going to live and be housed? I think human nature is such
that you kinda want to have something of your own to point to. If you know
what I mean? (Scientist 4, USA 2009)
7 The European Commission has provided Sixth Framework Programme funds to integrate data
emerging from the variety of mouse projects in CASIMIR (Coordination and Sustainability of
International Mouse Informatics Resources). Although KOMP is a trans-NIH initiative, the larger
amount of funding for the integration of gene and phenotype data for mutant mice has come through
Europe.
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The potential of KOMP is underpinned by the visions of a big biology, unfolding through
the co-production of a global scientific community, which shares data and biological
resources, centred around large research centres. For its proponents, this centrally organised
project is still the best way of accelerating insights from genetic resources for translational
research. In this sense, it is framed as a successor to the HGP. It may never ‘capture the
imagination, the way of “I can sequence a whole genome”, but I do think it’s how we’re
going to learn what each gene does’ (Scientist 5, Singapore 2009). The central assumption
of KOMP is that organisation is ultimately better than serendipity; biological complexity or
‘mess’ is inevitable, but standardisation and central organisation is essential for the
effective utilisation of genetic resources. However, even its proponents acknowledge it is
not the only route. There are opportunities, but there are recognised costs. For the diversity
of biological researchers making up the mouse community, with a history one respondent
compares to a cottage industry, it represents a significant and not always welcome shift.
Furthermore, as the complexities of characterizing and defining genes, phenotypes, animals
and environments across complex time-space patterns mount up, so do questions about the
overall value of centralisation, and whether massing animals and amassing data in this way
is the most efficient, effective and ethical way to further biological understanding of genetic
resources for translational research. There are biological, sociological and spatial
challenges, and there is not one solution.
The Distributed Management of Biological Resources
‘We spend a lot of time on management because we see opportunities in this
industry, that haven't yet been realised on how management can improve how we do
things faster, better, cheaper, like you see in almost every other industry, but it’s
been very late coming to ours’ (Scientist 6, USA 2009).
In another interview, within the biological resource centre of a large American university
hospital, I encounter a different understanding of my research. The meeting starts in an
unexpected way. Uniquely, I am not asked to explain why a geographer is researching the
production and circulation of mutant mice. I have seen this researcher talk at conferences,
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and sent some explanatory sentences on my interests. In our opening conversation, he
reflects back to me the importance of geography in identifying challenges and opportunities
for contemporary laboratory animal science, much of which remains trapped in local frame
and scale.
‘Geography, in your definition of geography, is extremely important and biomedical
science is experiencing a geographical shift today. Whether they know or care, it is
going to have pretty big implications on how science gets done.’ (Scientist 6)
Questions of space permeate our conversation, ranging across scales from the potential for
the international offshoring of biological resource centres to the growing use of radio
frequency information devices (RFID) to monitor movements within laboratory spaces.
This individual is involved in managing the provision of specialised mouse strains within
his organisation, a task both providing services and shaping biological approaches. He is
also working internationally and is well respected, but he is not directly involved in KOMP.
Instead of looking to imitate European databases, he is seeking to emulate the spatial
practices of successful industries. Alongside biological research, he is reading management
theory, citing journalist Thomas Friedman on globalisation. He suggests the reorganization
of biological and experimental practices across space is essential to maximising the value
of genetic resources. He recognises this might be radical given the reluctance of scientists
to explore sub-disciplines down the hallway, which is ‘the next and obvious step for people
to take before they go across town, much less across the ocean’. But, he is confident the
international reorganisation of research is vital for translational research using genetically-
altered animal models, in the light of biological complexity and the potential for
personalised medicine. In this imaginary, the spatialities are flat rather than hierarchical,
expertise is mobile rather than nationally organised, differences incorporated into
experimental systems rather than standardised, and costs saved through management at the
margins rather than coordination at the centre. The spatial dimensions to this enterprising
logic are intriguing and despite their clear articulation with the spatial logics of neoliberal
economics, their biological and ethical implications are not so easily categorised.
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First, reducing costs is related to enhancing the ability of research to cope with the growing
scope of biological enquiry, not only by standardisation but also by taking difference
seriously. This is not the search for economies of scale through the uniformity of biological
resources. Rather their work with genetically-altered mice has been central to a growing
recognition of complexity. As he suggests, ‘we’re no longer simply interested in an animal
living or dying [...] now we’re focusing on specific receptive molecules, we’re focusing on
gene activation, and we’re focusing on genetic differences between individual animals’.
The need to produce data at a higher resolution, and for more animals, is seen as essential
to reaping potential rewards of genetic understandings for translational research and
personalised medicine8. As the complexity of biological understanding increases, so does
the value of research animals, and the requirements for information about their care and
their environment, especially their husbandry, microbiology and health. This challenge is
shared in KOMP, but here demand for detailed data puts the whole organism in its
environment, rather the gene itself, at the centre of attempts to utilise the value of genetic
resources. There is some standardisation; contemporary biological research still requires a
well-characterised genotype, but this is not standardisation around one inbred strain in a
single project. It also extends consideration to the life experiences of the individual animal.
Pressure from humane societies, in raising awareness throughout the laboratory animal
community, is welcomed as a means to support forms of care that might extend the lives of
animals and aid translation of data between animal model and clinical practices. This point
is explained to me in detail, and on more than one occasion.
‘If you want to talk about personalised medicine models [...] that requires a lot
more investment in the care and the environment of that animal. So we as lab
animal care providers, are giving to our customers, the scientists, as well-
defined and as least variable an organism or a model or an entity as possible, so
that you avoid a lot of the statistical noise that you might see otherwise.
8 Developments in personalised medicine are changing the way model organisms are being used in
experimental and translational research. Whereas conventional biological research using model
organisms relies on statistical models to make judgements about the safety and efficacy of new
therapeutic interventions at the level of populations, personalised medicine seeks to examine the
wide range of data relevant to the genetic profile of individuals being treated. See for example
Davies (2012a).
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Coupled with that is much more public awareness, concern, scrutiny of how
animals are used and how they’re cared for in the lab. So there’s a lot more
attention being paid on things that 10 or 20 years ago, weren’t very common.
Post operative analgesics for mice, routine today, wasn't even considered
critical 20 years ago […] There’s a much greater investment in time and money
into these animals, to give scientists the evolving detailed data that they need.’
(Scientist 6)
The growing importance of attention to both animal genotype and environment, and the
investments of time and money into research animals, is shared in discussions of KOMP.
However, what is different in this spatial imaginary is that doing things ‘faster, better and
cheaper’ is not about managing biological resources through centralised projects in the
USA and Europe, but about redistributing research practices across space, to reduce costs
and enhance sensitivity to biological difference. He reckons about 25-30% of the mouse
capacity at any major research institute today is devoted to breeding. Animal facilities are
expensive to maintain in the USA. They are also costly to build, and facilities are running
out of room. In his institution, they are searching for places, overseas, ‘that are doing things
acceptably well for a whole lot less money’. He is looking to locate mouse facilities
overseas, building a satellite breeding and holding facility in China, which would operate
under the supervision of the US resource centre. Most experimental practices would remain
in the USA, but breeding and cryopreservation would take place elsewhere, with frozen
embryos shipped back to be re-implanted into animals in the USA. There are still questions
to be resolved: over reliability, protection of intellectual property and veterinary
competency and authority. Vets have final authority on animal procedures in the USA; in
China, the scientist is in charge in the final instance. But he praises the pragmatism he finds
outside the USA and Europe. Overseas laboratories who want to collaborate are rapidly
seeking AAALAC accreditation9, which requires them to adopt US animal care guidelines,
so for him trust and understanding are slowly being built.
9 Association for Assessment and Accreditation of Laboratory Animal Care International
http://www.aaalac.org/ Last accessed 16.03.2012.
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This vision of the future of international research using genetically-altered animals
configures the intersection of the sociological, biological and spatial differently. As in
KOMP, there are opportunities and there are potential risks, but these are rather differently
distributed. Managing research across different places, rather than centralising research
practices, removes some of the sociological challenges. It is less dependent on the co-
construction of a shared global scientific community, treating scientists as specialised
customers rather than a single community. Collaboration and trust are sought through
quality assurance rather than through creating collective identities. It is also more agnostic
about the experimental biological practices through which new insights might emerge.
Biological differences encountered in other places become potentially relevant for
developing personalised medicine and furthering the scope of translational research. In this
sense, space, or geography, is not only a resource managed to reduce costs, it can also add
value for US and Chinese partners. As he reflects,
‘Ethnic minorities in China have very different rates of cancer [...] Is it diet, is it
genetics, is it a combination of both? And combine with that a lot of these ethnic
minorities have their own traditional medicines specific for this. So one of the
research programmes we’re discussing with our Chinese contacts, is to establish in
combination with this mouse breeding service [...] I don't know what the right
phrase is, a localised cancer research initiative for each one of these outlying
populations. Then can we start looking at extracts of all these traditional medicines
that have been evolving for centuries with those cultures, to see if there’s any gold
in some of the elements that go into those concoctions. And then treat those
xenograft mice bearing those tumours with extracts, to see if we can find a new
cancer drug. It may be active only to those genotypes or it may be active to all
humans, we don't know. But this is where we see geography now contributing to
medical science. ‘(Scientist 6)
The imaginaries of this research are more spatially extensive and biologically distributed.
The previous focus on European and North American research is widened as Asia enters
the conversation. The response of research to biological differences is more distributed than
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in the central integration of KOMP. This is science framed through biological emergence
and economic imperatives, realised through management at a distance; a conjuncture of
practices resonating with other accounts where transnational neoliberalism meets biocapital
(Cooper 2008). It is still underpinned by a central political vision, of science as an
international endeavour, regulated through quality assurance mechanisms, but without the
centralizing practices for animals, people and places in a project like KOMP. In the end,
this individual is fairly scathing about the potential of centrally directed ‘big biology’, to
maximise understandings in functional genomics or improve animal welfare.
‘People are now looking for ways to justify the huge costs that have been made in
these large lists, as opposed to letting nature tell us […] on an ad hoc, case by case
basis. Because if you went back to these large centres for phenotyping cores and
asked them what was their yield, what was their return on investment, how many
surprises did they discover that were actually either of major animal welfare impact
or of additional scientific value? I’m guessing that percentage is very low. It was a
very logical edifice to construct earlier and a very logical concept to emerge, but in
a performance based mentality, is it still adding value? It’s very expensive and so
let’s move on’ (Scientist 6)
In this framing, new biological understandings emerge from being open to surprise (Braun
2008). Biological complexity is not seen as amenable to the logics of centralised
engineering. Rather the management and understanding of experimental excess, for both
human and animal health, has to be negotiated on asking on a case-by-case basis: ‘have we
created an animal that clearly is in a worse state than it was before and do we need to
provide additional veterinary accommodations for that animal? Or have we now created an
animal where the accident is of scientific value?’ Answering this question requires the
spread of surveillance technologies of both animals and animal care-takers. There is a link
between the internationalization of science and the monitoring of space at the smallest
scale, in laboratory, even the cage. Being able to answer questions about animal welfare or
scientific value requires skilled technicians to work with animals, wherever they are to be
housed. Our conversation ends with a discussion about the emerging use of RFID
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technologies to track laboratory animals, providing biological data on animal behaviour or
monitoring institutional processes as cages and people move around10. Conformities can be
achieved through such devices without requiring technicians or researchers to invest in a
central biological project or share the same notions of a global scientific community. This
is arguably not ‘big biology’, but an assemblage of international technoscientific practices,
animated by the language of customers and the distributed management of animal and
human life.
Conclusions
This paper has presented two distinct visions for the future of international collaborative
biology as research with mutant mice gathers in pace and scale. The two approaches
embody different biological assumptions, sociological challenges and spatial imaginaries in
the search for effective means of developing mouse genetic resources for translational
research. These are not the only ones, and they are not exclusive, but I argue they are
instructive for considering what is at stake in the contemporary intersection of the
biological, sociological and spatial. The first centres on the integrative practices of KOMP,
as animals and researchers are reorganised around shared animals, databases and
infrastructures. The second highlights an alternative vision, using distributed management
to reduce costs and enhance the potential for biological insights to emerge across space.
These international visions cannot be explained by attending only to the local assemblage
of technological and biological artefacts through which research is mobilised and scale
emerges. Rather, these assemblages are composed and animated in part through such
biological, sociological and spatial imaginaries from the outset, with implications for the
individual scientists, national institutions and research animals involved. These different
10 There are emerging discussions about how RFID technologies might be used to train animal
caretakers to work with animals in standardised ways, by training bodily movements, rather than
disseminating written instruction. Attach sensors and transmitters to the room, cage-racks and
sleeves of staff, set the standard operating procedures for a given task, for example handling micro-
isolator cages, and each person can then be evaluated, for efficiency and precision, against the
programmed sequence of movements. This development is still nascent but has the potential to
transform discussions about the value of tacit knowledge in relation to both the geographies of
scientific knowledge and embodied practices of animal care.
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spatialisations are simultaneously political-economic and techno-scientific (Parry 2004;
Braun 2006). Both indicate a different settlement in the oscillation between the centripetal
practices of standardisation in experimental biology and the more centrifugal demands of
translational research, and the value of centralisation and the valorisation of difference in
economic organisation and scientific research. For both, their spatial imaginaries come at a
complex conjuncture of late capitalist economic organisation, the internationalisation of
science and the postgenomic sciences, whose intersecting contours are currently hard to
pull apart.
In the early 2000s, influential work by Franklin et al (2000) drew attention to the
emergence of the ‘global biological’ in relation to international developments in stem cell
research and genomic technologies. The spatial and biological forms underpinning the
global reach and ambition of these technologies were ‘predicated on the reduction of nature
to the molecule or the gene’ (Braun 2006, p.650). This conceptualisation draws attention to
the ‘double reductionism’ involved in earlier battles over biotechnology (McAfee, 2003).
First, biological reductionism extracted genes and molecules from their ‘cellular,
environmental and cultural contexts’ (Braun, 2006, p.650). This genetic reductionism
enabled the economic reductionism through which genes were circulated as tradable
commodities, enclosed via property rights. Through such means genes were constructed as
essentially ‘placeless’, susceptible to de-localization and circulation. The
informationalisaiton of biology around genetics was seen to herald a particular mobilisation
and globalisation of molecular life (Rose 2007).
In conclusion, I want to suggest the postgenomic sciences are reopening the spatial
assumption of the ‘global biological’. Of course this transcendence of space was never
achieved, and only sometimes claimed, but the return of attention to the spatialisation of
biology and value in the experimental and management practices of the postgenomic
sciences demands detailed consideration. This can be exemplified in the challenge of
centralising animals and data in KOMP, which not only involves uniform animals and gene
ontologies, but also careful considerations of environment, from the scale of the body to the
located practices of animal husbandry. In many ways, KOMP inherited the genetic
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reductionism from the early Human Genome Project, working sequentially and logically
through the genome of a single animal. The subsequent ‘respatialization’ of biological
research, partly emerging out of projects like KOMP, thus presents a challenge to its
directed organisation. The registers of centralisation in play, which are simultaneously
biological, geographical and sociological, are tricky to align and to that extent do challenge
the idea of KOMP as an obvious successor to the HGP.
The alternative presented above is an economic reorganisation, epistemic agnosticism and
increased surveillance. It is possible to see in this attentiveness to biological emergence
conceptual confirmation of a ‘neoliberal biological’ science, with its rolling back of central
state-based organisation and rescaling of regulatory capacities around audit cultures.
However, here too, these biological, sociological and spatial imperatives do not map neatly
onto one another, and there is more space to articulate alternative ethical and postcolonial
perspectives in this distributed management of mutant mouse resources. Collapse questions
of biological organisation and neoliberal economics too quickly and there is a risk of spatial
reductionism too, extrapolating from the historical experience of western science and
closing down the questions about the operation of biological contextualisation within
postgenomics. If we are to understand the emerging contours of this arguably big biology I
suggest we need careful mapping of its spatial complexities and reflexivity about the role of
sociological abstractions in our own social science research as well (Castree 2005).
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